307 related articles for article (PubMed ID: 8567021)
1. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva.
Sweet SP; Rahman D; Challacombe SJ
Immunology; 1995 Dec; 86(4):556-9. PubMed ID: 8567021
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome.
Chaushu S; Chaushu G; Zigmond M; Yefenof E; Stabholz A; Shapira J; Merrick J; Bachrach G
Arch Oral Biol; 2007 Nov; 52(11):1088-96. PubMed ID: 17658453
[TBL] [Abstract][Full Text] [Related]
3. Salivary immunoglobulin A and G subclasses in HIV positive patients.
Sistig S; Lukac J; Vucicevic-Boras V; Delic D; Kusic Z
Eur J Med Res; 2003 Dec; 8(12):543-8. PubMed ID: 14711601
[TBL] [Abstract][Full Text] [Related]
4. Both IgA subclasses are reduced in parotid saliva from patients with AIDS.
Müller F; Frøland SS; Hvatum M; Radl J; Brandtzaeg P
Clin Exp Immunol; 1991 Feb; 83(2):203-9. PubMed ID: 1899629
[TBL] [Abstract][Full Text] [Related]
5. Salivary and mucosal immune responses to HIV and its co-pathogens.
Challacombe SJ; Sweet SP
Oral Dis; 1997 May; 3 Suppl 1():S79-84. PubMed ID: 9456663
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of IgA1-IgA2 levels in serum and saliva of young and elderly people.
Ventura MT
Allergol Immunopathol (Madr); 1991; 19(5):183-5. PubMed ID: 1811413
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.
Coogan MM; Sweet SP; Challacombe SJ
Infect Immun; 1994 Mar; 62(3):892-6. PubMed ID: 8112860
[TBL] [Abstract][Full Text] [Related]
9. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
Engström PE; Gustafson R; Granberg M; Engström GN
Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
[TBL] [Abstract][Full Text] [Related]
10. Comparison of salivary IgA and systemic IgA and IgG antibodies to Saccharomyces cerevisiae in HIV-infected subjects.
Belazi M; Fleva A; Drakoulakos D; Panayiotidou D
Int J STD AIDS; 2003 Jul; 14(7):458-62. PubMed ID: 12869225
[TBL] [Abstract][Full Text] [Related]
11. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly.
Eliasson L; Birkhed D; Osterberg T; Carlén A
Eur J Oral Sci; 2006 Dec; 114(6):494-9. PubMed ID: 17184231
[TBL] [Abstract][Full Text] [Related]
12. Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.
Savage NW; Barnard K; Shirlaw PJ; Rahman D; Mistry M; Escudier MP; Sanderson JD; Challacombe SJ
Clin Exp Immunol; 2004 Mar; 135(3):483-9. PubMed ID: 15008983
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of analysis of immunoglobulin A levels in saliva].
Bokor-Bratić M
Med Pregl; 2000; 53(3-4):164-8. PubMed ID: 10965682
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on immunoglobulin A subclass distribution in human parotid saliva.
Childers NK; Greenleaf C; Li F; Dasanayake AP; Powell WD; Michalek SM
Oral Microbiol Immunol; 2003 Oct; 18(5):298-301. PubMed ID: 12930521
[TBL] [Abstract][Full Text] [Related]
15. Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.
Wu X; Jackson S
J Clin Immunol; 2002 Mar; 22(2):106-15. PubMed ID: 11998891
[TBL] [Abstract][Full Text] [Related]
16. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
17. Immunological findings in whole and parotid saliva of patients with ulcerative colitis and healthy controls.
Crama-Bohbouth G; Peña AS; Verspaget HW; vd Zon A; Biemond I; Weterman IT; Lamers CB
Hepatogastroenterology; 1989 Aug; 36(4):185-7. PubMed ID: 2807134
[TBL] [Abstract][Full Text] [Related]
18. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.
Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C
Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823
[TBL] [Abstract][Full Text] [Related]
19. Subclass distribution of antigen-specific IgA antibodies in normal donors and individuals with homozygous C alpha 1 or C alpha 2 gene deletions.
Engström PE; Norhagen G; Bottaro A; Carbonara AO; Lefranc G; Steinitz M; Söder PO; Smith CI; Hammarström L
J Immunol; 1990 Jul; 145(1):109-16. PubMed ID: 2162886
[TBL] [Abstract][Full Text] [Related]
20. Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.
Belec L; Meillet D; Gaillard O; Prazuck T; Michel E; Ngondi Ekome J; Pillot J
Clin Exp Immunol; 1995 Jul; 101(1):100-6. PubMed ID: 7621578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
